CIK 0001674416 · Large accelerated filer
CRISPR Therapeutics AG
Sign in to watch- Ticker
- CRSP
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- operating
- EIN
- 473173478
- Phone
- 6173154600
- Business address
- BAARERSTRASSE 14, ZUG, Switzerland
- Former names
- CRISPR Therapeutics AG
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,881,673
- in 7 filings, $1.5M under 10b5-1 plans
Net −$4,881,673. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-09-09 | Bolzon Bradley J PhD Director | Other disposition | −42,272 | 0 | ||
| 2020-09-09 | Bolzon Bradley J PhD Director | Other acquisition | +7,391 | 7,391 | ||
| 2020-09-02 | Kulkarni Samarth Chief Executive Officer | Shares withheld for taxes | −779 | $94.15 | $73K | 169,968 |
| 2020-09-01 | TOMSICEK MICHAEL JOHN Chief Financial Officer | Option exercise | +12,000 | $17.75 | $213K | 12,410 |
| 2020-09-01 | TOMSICEK MICHAEL JOHN Chief Financial Officer | Sale | −2,800 | $91.39 | $256K | 9,610 |
| 2020-09-01 | TOMSICEK MICHAEL JOHN Chief Financial Officer | Sale | −6,400 | $92.23 | $590K | 3,210 |
| 2020-09-01 | TOMSICEK MICHAEL JOHN Chief Financial Officer | Sale | −2,800 | $93.18 | $261K | 410 |
| 2020-09-01 | TOMSICEK MICHAEL JOHN Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −12,000 | 156,000 | ||
| 2020-09-01 | Novak Rodger President | Option exercise | +3,933 | $14.00 | $55K | 651,940 |
| 2020-09-01 | Novak Rodger President | Option exercise | +21,067 | $14.43 | $304K | 673,007 |
| 2020-09-01 | Novak Rodger President | Sale | −1,406 | $91.54 | $129K | 671,601 |
| 2020-09-01 | Novak Rodger President | Sale | −19,754 | $92.59 | $1.8M | 651,847 |
| 2020-09-01 | Novak Rodger President | Sale | −3,840 | $93.19 | $358K | 648,007 |
| 2020-09-01 | Novak Rodger President | Option exercise · Stock Option (Right to Buy) | −3,933 | 111,893 | ||
| 2020-09-01 | Novak Rodger President | Option exercise · Stock Option (Right to Buy) | −21,067 | 215,315 | ||
| 2020-09-01 | Bolzon Bradley J PhD Director | Option exercise | +30,000 | $14.00 | $420K | 30,000 |
| 2020-09-01 | Bolzon Bradley J PhD Director | Option exercise | +15,000 | $13.62 | $204K | 45,000 |
| 2020-09-01 | Bolzon Bradley J PhD Director | Option exercise | +15,000 | $59.31 | $890K | 60,000 |
| 2020-09-01 | Bolzon Bradley J PhD Director | Sale | −4,300 | $91.27 | $392K | 55,700 |
| 2020-09-01 | Bolzon Bradley J PhD Director | Sale | −36,365 | $92.40 | $3.4M | 19,335 |
Page 40 of 46 · 910 trades